Literature DB >> 12527572

Diagnosis of lung cancer: the guidelines.

M Patricia Rivera1, Frank Detterbeck, Atul C Mehta.   

Abstract

Lung cancer is usually suspected in individuals who have abnormal chest radiograph findings or have symptoms caused by either local or systemic effects of the tumor. The method of diagnosis of suspected lung cancer depends on the type of lung cancer (ie, small cell lung cancer or non-small cell lung cancer), the size and location of the primary tumor, the presence of metastasis, and the overall clinical status of the patient. Achieving a diagnosis and staging are usually done in concert because the most efficient way to make a diagnosis often is dictated by the stage of the cancer. The best sequence of studies and interventions in a particular patient involves careful judgment of the probable reliability of a number of presumptive diagnostic issues, so as to maximize the sensitivity and to avoid performing multiple or unnecessary invasive procedures. In this article, we consider all manner of clinical presentations of lung cancer in light of currently available diagnostic procedures. Published data supporting a particular diagnostic approach is weighed based on the quality of the benefit as well as the estimated net benefit. Recommendations are graded in terms of strength to provide clinicians with guidance as to the most efficient and approach to the diagnosis of lung cancer in individual patients.

Entities:  

Mesh:

Year:  2003        PMID: 12527572     DOI: 10.1378/chest.123.1_suppl.129s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

Review 1.  Best practice in primary care pathology: review 8.

Authors:  W S A Smellie; K K Hampton; R Bowley; R Bowlees; S C Martin; N Shaw; J Hoffman; J P Ng; S M Mackenzie; C van Heyningen
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

2.  Respiratory-induced errors in tumor quantification and delineation in CT attenuation-corrected PET images: effects of tumor size, tumor location, and respiratory trace: a simulation study using the 4D XCAT phantom.

Authors:  Parham Geramifar; Mojtaba Shamsaie Zafarghandi; Pardis Ghafarian; Arman Rahmim; Mohammad Reza Ay
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

3.  ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.

Authors:  Wei Zhao; Hui Wang; Yan Peng; Bo Tian; Lei Peng; Da-Chuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Perilesional emphysema as a predictor of risk of complications from computed tomography-guided transthoracic lung biopsy.

Authors:  Doo Sik Lee; So Hyeon Bak; Yong Hwan Jeon; Sung Ok Kwon; Woo Jin Kim
Journal:  Jpn J Radiol       Date:  2019-09-20       Impact factor: 2.374

5.  EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection.

Authors:  Sinchita Roy Chowdhuri; Liqiang Xi; Trinh Hoc-Tran Pham; Jeffrey Hanson; Jaime Rodriguez-Canales; Arlene Berman; Arun Rajan; Giuseppe Giaccone; Michael Emmert-Buck; Mark Raffeld; Armando C Filie
Journal:  Mod Pathol       Date:  2011-12-09       Impact factor: 7.842

6.  Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease.

Authors:  Stephen Deppen; Joe B Putnam; Gabriela Andrade; Theodore Speroff; Jonathan C Nesbitt; Eric S Lambright; Pierre P Massion; Ron Walker; Eric L Grogan
Journal:  Ann Thorac Surg       Date:  2011-05-18       Impact factor: 4.330

7.  TGF-β1 serum concentration as a complementary diagnostic biomarker of lung cancer: establishment of a cut-point value.

Authors:  Ana E González-Santiago; Luz A Mendoza-Topete; Francisco Sánchez-Llamas; Rogelio Troyo-Sanromán; Carmen M Gurrola-Díaz
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

8.  Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET.

Authors:  Annarita Ianniello; Maddalena Sansovini; Stefano Severi; Silvia Nicolini; Chiara Maria Grana; Katrin Massri; Alberto Bongiovanni; Lorenzo Antonuzzo; Valentina Di Iorio; Anna Sarnelli; Paola Caroli; Manuela Monti; Emanuela Scarpi; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-27       Impact factor: 9.236

9.  3D MDCT-based system for planning peripheral bronchoscopic procedures.

Authors:  Jason D Gibbs; Michael W Graham; William E Higgins
Journal:  Comput Biol Med       Date:  2009-02-12       Impact factor: 4.589

10.  Semiautomated laser capture microdissection of lung adenocarcinoma cytology samples.

Authors:  Sinchita Roy Chowdhuri; Jeffrey Hanson; Jerome Cheng; Jaime Rodriguez-Canales; Patricia Fetsch; Ulysses Balis; Armando C Filie; Giuseppe Giaccone; Michael R Emmert-Buck; Jason D Hipp
Journal:  Acta Cytol       Date:  2012-11-24       Impact factor: 2.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.